Omada Health aims to go public with market cap of up to $1.1 billion

Omada Health is gearing up for its initial public offering (IPO) with plans to raise as much as $158 million, potentially achieving a market capitalization of approximately $1.1 billion at the upper end of its anticipated price range. The company, which specializes in virtual chronic care, recently updated its filing, indicating a share price range of $18 to $20. In total, Omada intends to offer 7.9 million shares, although both the offering size and share price may fluctuate, and the market cap could increase on a fully diluted basis. The IPO is slated for next week, marking a significant moment as Omada becomes the second digital health enterprise to enter the public market in recent weeks, following the debut of digital physical therapy firm Hinge Health on the New York Stock Exchange earlier this month. Based in San Francisco, Omada promotes what it calls a 'between-visit care model' designed to enhance the overall healthcare system, as outlined in its prospectus. The company was co-founded in 2012 by Sean Duffy, who currently serves as CEO, alongside Andrew DiMichele and Adrian James, both of whom have since pursued other ventures. According to the filing, Omada's revenue surged by 57% in the first quarter, reaching $55 million compared to $35.1 million during the same period last year. For the fiscal year 2024, revenues are projected to increase by 38%, hitting $169.8 million, up from $122.8 million in 2023. The company has also reported a reduction in net loss, narrowing to $9.4 million in the first quarter from $19 million a year prior. In his message to potential investors, Duffy expressed gratitude for their interest in Omada and extended an invitation to join the company on its journey. The firm will list on the Nasdaq under the ticker symbol 'OMDA,' with Morgan Stanley, Goldman Sachs, and JPMorgan Chase leading the offering. Notable investors in Omada include U.S. Venture Partners, Andreessen Horowitz, and Fidelity.